Talizumab

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTalizumab

Drug Alias NameHU 901TNX 901Anti-IgE monoclonal antibody Hu 901

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionImmunosuppressants

TargetsImmunoglobulin E

Therapy Area/IndicationsPeanut Hypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTanox Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTanox Inc

Active IndicationsN/A

Inactive IndicationsPeanut Hypersensitivity

ATC CodeN/A